Marvel Biosciences Announces Positive Interim Results for Autism Treatment with MB204
substantial potential of MB204 to address the core symptoms of autism.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 CAD | +11.11% | -13.04% | +25.00% |
1st Jan change | Capi. | |
---|---|---|
+25.00% | 2.63M | |
+44.31% | 54.04B | |
+43.57% | 41.96B | |
-1.25% | 41.92B | |
-7.59% | 28.35B | |
+12.19% | 26.35B | |
-21.99% | 19B | |
+7.26% | 13B | |
+29.40% | 12.28B | |
+25.21% | 12.19B |